Current studies have shown the potential vulnerability of UCS to immunotherapy, so only a few studies have elucidated the inhibitory effect of PD-1/PD-L1 in the treatment of uterine leiomyosarcoma [16]. Here, CD274 is linked to leiomyosarcoma.